Treatment of the primary hyperoxalurias: a new chapter
- PMID: 16988727
- DOI: 10.1038/sj.ki.5001821
Treatment of the primary hyperoxalurias: a new chapter
Abstract
Despite advances in the enzymology, molecular genetics, and clinical knowledge of the primary hyperoxalurias, few treatments are available. Oxalobacter formigenes is a promising new therapy with potential to induce secretion of oxalate into the intestinal lumen, where it can be degraded by the bacteria.
Comment on
-
Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1.Kidney Int. 2006 Oct;70(7):1305-11. doi: 10.1038/sj.ki.5001707. Epub 2006 Jul 19. Kidney Int. 2006. PMID: 16850020 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
